Neural tube defects between folate metabolism and genetics

Indian Journal of Human Genetics

Volumn 17, Issue 3, 2011, Pages 126-131

  Alfarra, Helmi Y ^a   Alfarra, Sabreen R ^a   Sadiq, Mai F ^a  

^a YARMOUK UNIVERSITY   (Jordan)

Author keywords

Folic acid; MTHFR; MTR; MTRR; NTDs

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE; METHIONINE SYNTHASE;

CYANOCOBALAMIN DEFICIENCY; DISEASE ASSOCIATION; DNA CONFORMATION; DNA METHYLATION; FOLATE METABOLISM; GENE EXPRESSION; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; NEURAL TUBE DEFECT; NEURULATION; REVIEW;

EID: 84856373202     PISSN: 09716866     EISSN: 1998362X     Source Type: Journal    
DOI: 10.4103/0971-6866.92082     Document Type: Review

References (40)

1. Brouns MR, Straaten HW. Models of neural tube defects. Drug Discov Today 2005;2:285-90. (Pubitemid 43071695)
2. Asindi A, Al-Shehri A. Neural tube defects in the Asir region of Saudi Arabia. Ann Saudi Med 2001;21:26-9. (Pubitemid 33094717)
3. Relton CL, Wilding CS, Pearce MS, Laffling AJ, Jonas PA, Lynch SA, et al. Gene-gene interaction in folate related genes and risk of neural tube defects in a UK population. J Med Genet 2003;41:256-60.
4. Zhu H, Wicker NJ, Shaw GM, Lammer EJ, Hendricks K, Suarez L, et al. Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mole Genet Metab 2002;78:216-21. (Pubitemid 36332023)
5. World Health Organization, 2006. Prevention of neural tube defects. Available from: http://www.who.int/makingpregnancy-safer/publications/en/. [Retrieved on 2008 Aug 30].
6. Rampersaud E, Bassuk AG, Enterline DS, George TM, Siegel DG, Melvin EC, et al. Whole genome wide link age screen for neural tube defects reveals regions of interest on chromosome 7 and 10. J Med Genet 2007;42:940-6. (Pubitemid 41811316)
7. Daoud A, Al-kaysi F, El-Shanti H, Batieha A, Obeidat A, Al-Sheyyab M. Neural tube defects in northern Jordan. Saudi Med J 1996;17:78-81. (Pubitemid 126501626)
8. Aqrabawi H. Incidence of Neural tube defects among neonates at King Hussein Medical Center, Jordan. Eastern Mediterranean Health J 2005;11:819-23.
9. Masri A. Neural tube defects in Jordan: A hospital based study. J Pediatr Neurol 2006;4:245-9. (Pubitemid 44920934)
10. Padmanabhan R. Etiology, pathogenesis and prevention of neural tube defects. Congenital Anomalies 2006;46: 55-67.
11. Rossi A, Biancheri R, Cama A, Piatelli G, Ravegnani M, Tortori-Donati P. Imaging in spine and spinal cord malformation. Eur J Radiol 2004;50:177-200. (Pubitemid 38469968)
12. Gos M, Szpecht-Potocka A. Genetic basis of neural tube defects: Irregulatory genes for the neurulation process. J Appl Genet 2002;43:343-50. (Pubitemid 135705671)
13. Catala M. Genetic control of caudal development. Clin Genet 2002;61:86-96.
14. Copp A, Greene N, Murdoch J. The genetic basis of neurolation. Nat Rev Genet 2003;4:784-93.
15. Lucock M. Folic acid: Nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 2000;71:121-38.
16. Fowler B. The folate cycle and disease in humans. Kidney Int 2001;59:S221-9. (Pubitemid 32144102)
17. Boyles LA, Hammoch P, Speer CM. Candidate gene analysis in human neural tube defects. Am J Med Genet Part C 2005;153C:9-23.
18. Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 2000;275:29,318-29,323. (Pubitemid 32043802)
19. Eto I, Krumdieck CL. Role of vitamin B12 and folate in carcinogenesis. In Essential Nutrients in Carcinogenesis. In: Poirier LA, Newberne PM, Pariza MW, editors. New York: Academic Press; 1986. p. 313-30.
20. Blount BC, Ames BN. DNA damage in folate deficiency. Bailleres Clin Haematol 1995;8:461-78.
21. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proc Natl Acad Sci USA 1997;94:3290-5.
22. Zingg JM, Jones PA. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis 1997;18:869-82. (Pubitemid 28132329)
23. Lindahl T, Wood RD. Quality control by DNA repair. Science 1999;286:1897-905. (Pubitemid 129515891)
24. Pancharuniti N, Lewis CA, Sauberlich HE, Perkins LL, Go RC, Alvarez JO, et al. Plasma homocysteine, folate and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr 1994;59:940-8. (Pubitemid 24112536)
25. Hibbard BM, Smithells RW. Folic acid metabolism and human embryopathy. Lancet 1965;1:1254.
26. Hibbard BM. The role of folic acid in pregnancy with particular reference to anaemia, abruption, and abortion. J Obstet Gynaecol Br Commonwlth 1964;71:529-42.
27. Steegers-Theunissen RP, Boers GH, Trijbels FJ, Eskes TK. Neural-tube defects and derangement of homocysteine metabolism. N Engl J Med 1991;324:199- 200.
28. Van der Put NM, Thomas CM, Eskes TK, Trijbels FJ, Steegers-Theunissen RP, Mariman EC, et al. Altered folate and vitamin B12 metabolism in families with spina bifida offspring. Q J Med 1997a;90:505-10. (Pubitemid 27379814)
29. Elwood J, Little J, Elwood J. Epidemiology and control of neural tube defects. Oxford: Oxford University Press; 1992.
30. Detrait ER, George TM, Etchevers HC, Gilbert JR, Vekemans M, Speer MC. Human neural tube defects: Developmental biology, epidemiology, and genetics. Neurotoxicol Teratol 2005;27:515-24. (Pubitemid 40804442)
31. Hol FA, van der Put NM, Geurds MP, Heil SG, Trijbels FJ, Hamel BC, et al. Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD1 (mthylenetetrahydrofolatecyclohdrolase, formyltetrahydrofolate synthase) in patients with neural tube defects. Clin Genet 1998;53:119-25. (Pubitemid 28188213)
32. Brody LC, Conley M, Cox C, Kirke PN, McKeever MP, Mills JL, et al. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate -dehydrogenase methenyltetrahydrofolate cyclohydrolase/ formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects. Am Soc Hum Genet 2002;71:1207-15. (Pubitemid 35305240)
33. Johanning GL, Wenstrom KD, Tamura T. Changes in frequencies of heterozygous thermolabile 5, 10-methylenetetrahydrofolate reductase gene in fetuses with neural tube defects. J Med Genet 2002;39:366-7. (Pubitemid 34526359)
34. Brody LC, Baker PJ, Chines PS, Musick A, Molloy AM, Swanson DA, et al. Methionine synthase: Highresolution mapping of the human gene and evaluation as a candidate locus for neural tube defects. Mol Genet Metab 1999;67:324-33. (Pubitemid 29406796)
35. Christensen B, Arbour L, Tran P, Leclerc D, Sabbaghian N, Platt R, et al. Enetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet 1999;84:151-7. (Pubitemid 29201082)
36. Gueant-Rodriguez RM, Rendeli C, Namour B, Venuti L, Romano A, Anello G, et al. Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans. Neurosci Lett 2003;344:189-92. (Pubitemid 36694675)
37. Greene ND, Stanier P, Copp AJ. Genetics of human neural tube defects. Hum Mole Genet 2009;18:R113-29.
38. Al Farra HY. Methionine synthase polymorphisms (MTR 2756 A>G and MTR 2758 C>G) frequencies and distribution in the Jordanian population and their correlation with neural tube defects in the population of the northern part of Jordan. Indian J Hum Genet 2010;16:72-7.
39. Kibar Z, Capra V, Gros P. Toward understanding the genetic basis of neural tube defects. Clin Genet 2007;71:295-310. (Pubitemid 46680796)
40. Franke B, Vermeulen SH, Steegers-Theunissen RP, Coenen MJ, Schijvenaars MM, Scheffer H, et al. An association study of 45 folate-related genes in spina bifida: Involvement of cubilin (CUBN) and tRNA aspartic acid methyltransferase 1 (TRDMT1). Birth Defects Res A Clin Mol Teratol 2009;85:216-26.